International Immunology, Vol. 13, No. 7, 959-967,
July 2001
© 2001 Japanese Society for Immunology
A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera
Correspondence to: D. N. J. Hart, Mater Medical Research Institute, Aubigny Place, Raymond Terrace, South Brisbane, Queensland 4101, Australia
CD83 is an inducible glycoprotein expressed predominantly by dendritic cells (DC) and B lymphocytes. Expression of membrane CD83 (mCD83) is widely used as a marker of differentiated/activated DC but its function and ligand(s) are presently unknown. We report the existence of a soluble form of CD83 (sCD83). Using both a sCD83-specific ELISA and Western blotting, we could demonstrate the release of sCD83 by mCD83+ B cell and Hodgkin's disease-derived cell lines, but not mCD83– cells. Inhibition of de novo protein synthesis did not affect the release of sCD83 during short-term (2 h) culture of cell lines although mCD83 expression was significantly reduced, suggesting sCD83 is generated by the release of mCD83. Isolated tonsillar B lymphocytes and monocyte-derived DC, which are mCD83low, released only low levels of sCD83 during culture. However, the differentiation/activation of these populations both up-regulated mCD83 and increased sCD83 release significantly. Analysis of sera from normal donors demonstrated the presence of low levels (121 ± 3.6 pg/ml) of circulating sCD83. Further studies utilizing purified sCD83 and the analysis of sCD83 levels in disease may provide clues to the function and ligand(s) of CD83.
Keywords: CD83, dendritic cell, soluble
1 Present address: Mater Medical Research Institute, Aubigny Place, Raymond Terrace, South Brisbane, Queensland 4101, Australia
Transmitting editor: J. Banchereau
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Clement, P. S. Bhattacharjee, H. E. Kaufman, and J. M. Hill Heat-Induced Reactivation of HSV-1 in Latent Mice: Upregulation in the TG of CD83 and Other Immune Response Genes and Their LAT-ICP0 Locus Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2855 - 2861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wilson, H. Cullup, R. Lourie, Y. Sheng, A. Palkova, K. J. Radford, A. M. Dickinson, A. M. Rice, D. N.J. Hart, and D. J. Munster Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease J. Exp. Med., February 16, 2009; 206(2): 387 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lechmann, N. Shuman, A. Wakeham, and T. W. Mak The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo PNAS, August 19, 2008; 105(33): 11887 - 11892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Reinwald, C. Wiethe, A. M. Westendorf, M. Breloer, M. Probst-Kepper, B. Fleischer, A. Steinkasserer, J. Buer, and W. Hansen CD83 Expression in CD4+ T Cells Modulates Inflammation and Autoimmunity J. Immunol., May 1, 2008; 180(9): 5890 - 5897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hansell, X. W. Zhu, H. Brooks, M. Sheppard, S. Withanage, D. Maskell, and I. McConnell Unique Features and Distribution of the Chicken CD83+ Cell J. Immunol., October 15, 2007; 179(8): 5117 - 5125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-C. Lundell, K. Andersson, E. Josefsson, A. Steinkasserer, and A. Rudin Soluble CD14 and CD83 from Human Neonatal Antigen-Presenting Cells Are Inducible by Commensal Bacteria and Suppress Allergen-Induced Human Neonatal Th2 Differentiation Infect. Immun., August 1, 2007; 75(8): 4097 - 4104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kummer, N. M. Turza, P. Muhl-Zurbes, M. Lechmann, C. Boutell, R. S. Coffin, R. D. Everett, A. Steinkasserer, and A. T. Prechtel Herpes Simplex Virus Type 1 Induces CD83 Degradation in Mature Dendritic Cells with Immediate-Early Kinetics via the Cellular Proteasome J. Virol., June 15, 2007; 81(12): 6326 - 6338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Prechtel, N. M. Turza, A. A. Theodoridis, and A. Steinkasserer CD83 Knockdown in Monocyte-Derived Dendritic Cells by Small Interfering RNA Leads to a Diminished T Cell Stimulation J. Immunol., May 1, 2007; 178(9): 5454 - 5464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Fries, J. Heukeshoven, I. Hauber, C. Gruttner, C. Stocking, R. H. Kehlenbach, J. Hauber, and J. Chemnitz Analysis of Nucleocytoplasmic Trafficking of the HuR Ligand APRIL and Its Influence on CD83 Expression J. Biol. Chem., February 16, 2007; 282(7): 4504 - 4515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dudziak, F. Nimmerjahn, G. W. Bornkamm, and G. Laux Alternative Splicing Generates Putative Soluble CD83 Proteins That Inhibit T Cell Proliferation J. Immunol., June 1, 2005; 174(11): 6672 - 6676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Klein, S. Koch, B. Borm, J. Neumann, V. Herzog, N. Koch, and T. Bieber CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells Int. Immunol., April 1, 2005; 17(4): 477 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zinser, M. Lechmann, A. Golka, M. B. Lutz, and A. Steinkasserer Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by Soluble CD83 J. Exp. Med., August 2, 2004; 200(3): 345 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Senechal, A. M. Boruchov, J. L. Reagan, D. N. J. Hart, and J. W. Young Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83 Blood, June 1, 2004; 103(11): 4207 - 4215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Munster, K. P. A. MacDonald, M. Kato, and D. J. N. Hart Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity Int. Immunol., January 1, 2004; 16(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kato, S. Khan, N. Gonzalez, B. P. O'Neill, K. J. McDonald, B. J. Cooper, N. Z. Angel, and D. N. J. Hart Hodgkin's Lymphoma Cell Lines Express a Fusion Protein Encoded by Intergenically Spliced mRNA for the Multilectin Receptor DEC-205 (CD205) and a Novel C-type Lectin Receptor DCL-1 J. Biol. Chem., September 5, 2003; 278(36): 34035 - 34041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Scholler, M. Hayden-Ledbetter, A. Dahlin, I. Hellstrom, K. E. Hellstrom, and J. A. Ledbetter Cutting Edge: CD83 Regulates the Development of Cellular Immunity J. Immunol., March 15, 2002; 168(6): 2599 - 2602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lechmann, D. J.E.B. Krooshoop, D. Dudziak, E. Kremmer, C. Kuhnt, C. G. Figdor, G. Schuler, and A. Steinkasserer The Extracellular Domain of CD83 Inhibits Dendritic Cell-mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells J. Exp. Med., December 17, 2001; 194(12): 1813 - 1821. [Abstract] [Full Text] [PDF]
|
|